CSPC Pharmaceutical (1093.HK)

HKSEHealthcare

HKD 8.21
-HKD 0.04 (-0.6%)
Market closed

May 8, 2026 at 16:00 UTC

Interactive Chart

1093.HK

11:59:30 UTC

About CSPC Pharmaceutical

Name
CSPC Pharmaceutical
CEO
Lei Cai
Industry
Healthcare
Year Founded
1997
Employees
21,400

CSPC Pharmaceutical Group is a healthcare company that researches, manufactures, and markets medicines through an integrated network of R&D centers, production sites, and distribution partners. The portfolio covers innovative therapies and well-established generics that address hospital and retail channels. Development teams progress candidates with a focus on clinical relevance and manufacturability rather than headline features. Commercial units coordinate medical education and supply so launches transition into stable availability. Manufacturing emphasizes quality systems and technology transfer that support consistent output across plants. The company serves domestic markets and selected international jurisdictions through registrations aligned with local standards. Within the pharmaceuticals sector, CSPC positions itself as a platform that links discovery with scaled delivery. Partnerships with ecosystem peers extend reach into specialty areas and adjacent services.

Analyst Ratings

Consensus Recommendation
Analyst consensus: 1 Buy, 15 Hold, 7 Sell
Buy1
Hold15
Sell7

Fundamentals & Financials

Revenue (TTM)
HKD 28.1B
Net Income (TTM)
HKD 4.1B
EPS (TTM)
HKD 0.37
ROA (TTM)
8.07%
Current Ratio
2.19
Dividend Yield
2.82%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

ItemQ4 2025
RevenueHKD 13,939.1M
Cost of SalesHKD 4,799.7M
Gross ProfitHKD 9,139.4M
Operating IncomeHKD 1,534.8M
Net IncomeHKD 1,460.6M
EPSHKD 0.13

Technical Indicators

CSPC Pharmaceutical's Technical Indicators Summary

1093.HK shows a bearish tilt as the market trades beneath a sequence of EMAs across short, medium and long horizons, and momentum readings including MACD are negative while RSI sits below neutral. Trend strength is modest rather than extreme, and volatility is moderate relative to the share price. On-balance volume is large but not showing clear accumulation, and the classic pivot is close to the current level, offering limited resistance. Technical takeaway: Bearish — price below key EMAs with negative momentum supports a cautious bearish technical stance.

Buy
1 signal
Neutral
15 signals
Sell
7 signals
Overall: Bearish30% Bearish signals
IndicatorValue
RSI (14)
37.15
Stochastic %K (14, 3, 3)
CCI (20)
WPR (14)
Momentum (10)
-0.78
MFI
17.88
MACD Level (12, 26)
-0.24
Bollinger Bands
ATR (14)
$0.34 (4.18%)
ADX (14)
20.42
OBV
471,981,988
Classic Pivot Point
$8.27
Fibonacci Pivot Point
$8.27
Simple Moving Averages
(5 indicators)
Exponential Moving Averages
$8.44 - $8.96(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

By the close, 1093.HK continued to sit slightly below yesterday’s 8.26, with a small -0.61% gap down and a finish near 8.21. Into the bell, a flat sector move (-0.47%) kept the backdrop muted. 1093.HK finished a touch below yesterday's close as the sector moved little and a small gap down kept the backdrop muted.

Price Change

from HKD 8.21 close

-HKD 0.01

Trading Volume

Below avg (73.5M)

61M

vs S&P 500 Today

Moderate Outperformance

+0.33%

52-Week Position

Mid-range

45.6%

Updated: May 8, 2026 at 08:02 UTC

Quote Summary

OpenPrevious Close
HKD 8.13HKD 8.21
Day Range52 Week Range
HKD 8.08 - HKD 8.23HKD 5.34 - HKD 11.63
VolumeAvg. Volume
67.3M86.1M
Market CapP/E Ratio
HKD 93.5B21.0